Modelling incremental benefits on complications rates when targeting lower HbA1c levels in people with Type 2 diabetes and cardiovascular disease
Sign Up to like & getrecommendations! Published in 2018 at "Diabetic Medicine"
DOI: 10.1111/dme.13533
Abstract: Glucose‐lowering interventions in Type 2 diabetes mellitus have demonstrated reductions in microvascular complications and modest reductions in macrovascular complications. However, the degree to which targeting different HbA1c reductions might reduce risk is unclear. read more here.
Keywords: incremental benefits; complications rates; hba1c; type diabetes ... See more keywords